1. Tareq AM, Mahmud MH, Billah MM, Hasan MN, Jahan S, Hossain MM, Chy FJ, Uddin MG, Emran TB and Sayeed MA. Fast-food and obesity: Status among the young adult population in Bangladesh. Narra J. 2022; 2(3): 1-7. [
DOI:10.52225/narra.v2i3.86]
2. Sidiq R, Ritawati, Sitio R and Hajar S. The risk of pneumonia among toddlers in Lambatee, Aceh. Kesmas. 2016; 11(2): 69-73. [
DOI:10.21109/kesmas.v11i2.1044]
3. Wang Q, Afshin A, Yakoob MY, Singh GM, Rehm CD, Khatibzadeh S, Micha R, Shi P and Mozaffarian D. Impact of nonoptimal intakes of saturated, polyunsaturated, and trans fat on global burdens of coronary heart disease. J. Am. Heart Assoc. 2016; 5(1): 1-23. [
DOI:10.1161/JAHA.115.002076]
4. Malekmohammad K, Bezsonov EE and Rafieian-Kopaei M. Role of lipid accumulation and inflammation in atherosclerosis: Focus on molecular and cellular mechanisms. Front. Cardiovasc. Med. 2021; 8(September): 1-16. [
DOI:10.3389/fcvm.2021.707529]
5. Yao Y, Liu F, Wang Y and Liu Z. Lipid levels and risk of new-onset atrial fibrillation: A systematic review and dose-response meta-analysis. Clin. Cardiol. 2020; 43(9): 935-43. [
DOI:10.1002/clc.23430]
6. Schwingshackl L, Heseker H, Kiesswetter E and Koletzko B. Reprint of: Dietary fat and fatty foods in the prevention of non-communicable diseases: A review of the evidence. Trends Food Sci. Technol. 2022; 130: 20-31. [
DOI:10.1016/j.tifs.2022.10.011]
7. Reston JT, Buelt A, Donahue MP, Neubauer B, Vagichev E and McShea K. Interventions to improve statin tolerance and adherence in patients at risk for cardiovascular disease: A systematic review for the 2020 U.S. department of veterans affairs and U.S. department of defense guidelines for management of dyslipidemia. Ann. Intern. Med. 2020; 173(10): 806-812. [
DOI:10.7326/M20-4680]
8. Virani SS, Smith SC, Stone NJ and Grundy SM. Secondary prevention for Atherosclerotic cardiovascular disease: Comparing recent US and European guidelines on Dyslipidemia. Circulation. 2020; 141(14): [
DOI:10.1161/CIRCULATIONAHA.119.044282]
9. Rea F, Biffi A, Ronco R, Franchi M, Cammarota S, Citarella A, Conti V, Filippelli A, Sellitto C and Corrao G. Cardiovascular outcomes and mortality associated with discontinuing statins in older patients receiving polypharmacy. JAMA Network Open. 2021; 4(6): 1-13. [
DOI:10.1001/jamanetworkopen.2021.13186]
10. Laurent C, Prieto-González S, Belnou P, Carrat F, Fain O, Dellal A, Cid MC, Hernández-Rodríguez J andMekinian A. Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu Arteritis. Scientific Reports. 2021; 11(1): 14404. [
DOI:10.1038/s41598-021-93416-0]
11. Meza-Contreras A, Wenczenovicz C, Ruiz-Arellanos K, Vesely EAKK, Mogollon R and Montori VM. Statin intolerance management: A systematic review. Endocrine. 2023; 79(3): 430-436. [
DOI:10.1007/s12020-022-03263-w]
12. Montastruc JL. Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins. Br. J. Clin. Pharmacol. 2023; 89(8): 2636-8. [
DOI:10.1111/bcp.15757]
13. García-Fernández-Bravo I, Torres-Do-Rego A, López-Farré A, Galeano-Valle F, Demelo-Rodriguez P and Alvarez-Sala-Walther LA. Undertreatment or overtreatment with Statins: Where are we? Front. Cardiovasc. Med. 2022; 9: 80871. [
DOI:10.3389/fcvm.2022.808712]
14. Sun L, Wolska A, Amar M, Zubirán R and Remaley AT. Approach to the patient with a suboptimal Statin response: Causes and algorithm for clinical management. J. Clin. Endocrinol. Metab. 2023; 108(9): 2424-34. [
DOI:10.1210/clinem/dgad153]
15. Maulydia NB, Khairan K, Tallei TE and Idroes R. Metabolomic profiling and anti-inflammatory activity of Blumea balsamifera : Insights from in silico and in vitro studies. Pharmacia. 2025; 72: 1-15. [
DOI:10.3897/pharmacia.72.e146995]
16. Hassanein MMM, Abdel-Razek AG, Al-Amrousi EF and Badr AN. Application of lime peel oil composite nanoemulsion to prevent toxigenic fungi in nuts. Heliyon. 2023; 9(8): e18620. [
DOI:10.1016/j.heliyon.2023.e18620]
17. Khutami C, Sumiwi SA, Khairul Ikram NK and Muchtaridi M. The Effects of antioxidants from natural products on Obesity, Dyslipidemia, Diabetes and their molecular Signaling mechanism. Int. J. Mol. Sci. 2022; 23(4): 1-23. [
DOI:10.3390/ijms23042056]
18. Chopra B and Dhingra AK. Natural products: A lead for drug discovery and development. Phytother. Res. 2021; 35(9): 4660-702. [
DOI:10.1002/ptr.7099]
19. Maulydia NB, Khairan K, Tallei T.E., Fauzi FM and Idroes R. Analysis of geothermal impact on metabolite compounds of heat-tolerant plant species using clustering and similarity cliff. Global Journal of Environmental Science and Management. 2024; 10(4): 1-16.
20. Shirisha Rao, Nadumane VK. Anti ovarian and cervical cancer potential of Tamarindus Indica Leaf ethanol crude extract and its bioactive fraction, Apigenin. JJBS. 2024; 17(3): 453-62. [
DOI:10.54319/jjbs/170307]
21. Ramya S, Narayanan V, Ponnerulan B, Saminathan E and Veeranan U. Potential of peel extracts of Punica granatum and Citrus aurantifolia on alloxan-induced diabetic rats. Beni-Suef Univer. J. Basic Appl. Sci. 2020; 9(1): 1-11. [
DOI:10.1186/s43088-020-00049-9]
22. Izah SC and Odubo TC. Effects of Citrus aurantifolia fruit juice on selected Pathogens of public health importance. ES Food and Agroforestry. 2023; 11(829): 1-14. [
DOI:10.30919/esfaf829]
23. Roko G, Dougnon VT, Hounkpatin A, Klotoé JR and Baba-Moussa L. Anti-inflammatory, analgesic and antipyretic properties of ethanolic extracts of three plants of Beninese's pharmacopoeia: Euphorbia hirta, Citrus aurantifolia and Heterotis rotundifolia. Asian J. Biol. 2020; 1-8. [
DOI:10.9734/ajob/2019/v8i430069]
24. Jain S, Arora P and Popli H. A comprehensive review on Citrus aurantifolia essential oil: Its phytochemistry and pharmacological aspects. Brazil. J. Natur. Sci. 2020; 3(2): 354-64. [
DOI:10.31415/bjns.v3i2.101]
25. Sitio R, Akmal M, Marlina M and Gholib G. Investigating ethanolic extract from acehnese lime (Citrus aurantifolia) peel as potential Anti-Hypercholesterolemia agent. J. Human. Earth. Future. 2024; 5(3): 348-65. [
DOI:10.28991/HEF-2024-05-03-04]
26. Wang M, Zhao H, Wen X, Ho CT and Li Sh. Citrus flavonoids and the intestinal barrier: Interactions and effects. Compr. Rev. Food Sci. Food Saf. 2021; 20(1): 225-51. [
DOI:10.1111/1541-4337.12652]
27. Al-Snafi AE. Blood lipids lowering effect of medicinal plants. GSCBPS. 2022; 19(3): 15-43. [
DOI:10.30574/gscbps.2022.19.3.0213]
28. Tavallali H, Bahmanzadegan A, Rowshan H and Tavallali V. Essential oil composition, antioxidant activity, phenolic compounds, total phenolic and flavonoid contents from pomace of Citrus aurantifolia. JMPB. 2021; 10(Special issue): 103-16.
29. Sitio R, Akmal M, Marlina and Gholib. Phytochemical screening of ethanolic extract of local Aceh lime (Citrus aurantifolia (Christm.) Swingle) peels. IOP Conference Series: Earth and Environmental Science. 2024; 1356: 12080. [
DOI:10.1088/1755-1315/1356/1/012080]
30. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye J-M, Lee ChH, Oh WK, Kim ChT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE and Kim JB. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006; 55(8): 2256-64. [
DOI:10.2337/db06-0006]
31. Ibrahim A, Shafie NH. Esa NM, Shafie SR, Bahari H and Abdullah MA. Mikania micrantha extract inhibits HMG-CoA Reductase and ACAT2 and ameliorates Hypercholesterolemia and Lipid Peroxidation in high cholesterol-fed rats. Nutrients. 2020; 12(10): 3077. [
DOI:10.3390/nu12103077]
32. Jia YJ, Xu RX, Sun J, Tang Y and Li JJ. Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats. J. Transl. Med. 2014; 12: 103. [
DOI:10.1186/1479-5876-12-103]
33. Nyambe-Silavwe H, Villa-Rodriguez JA, Ifie I, Holmes M, Aydin E, Jensen JM and Williamson G. Inhibition of human α-amylase by dietary polyphenols. Journal of Functional Foods. 2015; 19:723-32. [
DOI:10.1016/j.jff.2015.10.003]
34. Duwaerts CC, Maher JJ. Macronutrients and the adipose-liver axis in obesity and fatty liver. Cell. Mol. Gastroenterol. Hepatol. 2019; 7(4): 749-61. [
DOI:10.1016/j.jcmgh.2019.02.001]
35. Lee GH, Peng C, Park SA, Hoang TH, Lee HY, Kim J, Kang S-I, Lee Ch-H, Lee J-S and Chae H-J. Citrus peel extract ameliorates high-fat diet-induced NAFLD via activation of AMPK signaling. Nutrients. 2020; 12(3): 673. [
DOI:10.3390/nu12030673]
36. Uroko RI, Uchenna ON, Achi NK, Agbafor A, Egba SI and Orjiakor CA. The effects of the aqueous extracts of Elaeis guineensis fruits on the lipid profile and kidney function indices of male Wistar Albino rats. JJBS. 2019; 12(1): 5-16.
37. Bansal AB and Cassagnol M. HMG-CoA Reductase Inhibitors. StatPearls. 2023, Bookshelf ID: NBK542212.
38. Casula M, Colpani O, Xie S, Catapano AL and Baragetti A. HDL in atherosclerotic cardiovascular disease: In search of a role. Cells. 2021; 10(8): 1869. [
DOI:10.3390/cells10081869]
39. Patel KK and Kashfi K. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs. Biochem. Pharmacol. 2022; 196: 114654. [
DOI:10.1016/j.bcp.2021.114654]
40. Tabeshpour J, Hosseinzadeh H, Hashemzaei M and Karimi GHR. A review of the hepatoprotective effects of hesperidin, a flavanon glycoside in citrus fruits, against natural and chemical toxicities. DARU. 2020; 28(1): 305-17. [
DOI:10.1007/s40199-020-00344-x]
41. Rideout TC, Harding SV, Jones PJH and Fan MZ. Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities. Vasc. Health Risk Manag. 2008; 4(5): 1023-33. [
DOI:10.2147/VHRM.S3512]
42. van Bennekum AM, Nguyen DV, Schulthess G, Hauser H and Phillips MC. Mechanisms of cholesterol-lowering effects of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters. Br. J. Nutr. 2005; 94(3): 331-7. [
DOI:10.1079/BJN20051498]
43. Guyton AC and Hall JE. Textbook of Medical Physiology. 12th ed. Gruliow R, editor. Philadelphia: Elsevier Sounder; 2011, 1-1091 p.
44. Shi Z, Li T, Liu Y, Cai T, Yao W, Jiang J, He Y and Shan L. Hepatoprotective and anti-oxidative effects of total flavonoids from Qu Zhi Qiao (fruit of Citrus paradisi cv. Changshanhuyou) on nonalcoholic steatohepatitis In vivo and In vitro through Nrf2-ARE signaling pathway. Front. Pharmacol. 2020; 11: 483. [
DOI:10.3389/fphar.2020.00483]
45. Li S, Yin S, Ding H, Shao Y, Zhou S, Pu W, Han L, Wang T and Yu H. Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention. Cell Prolif. 2023; 56(1): e13346. [
DOI:10.1111/cpr.13346]
46. Shraideh Z, Badran DH, Alzbeede AA, Qattan D, Alzbeede AA and Friehat K. Effect of Garlic, Vitamin C, Vitamin E-Selenium against bioaccumulated Organolead-induced cellular injury in Liver and Spleen of Albino rats: pilot study. JJBS. 2021; 14(2): 285-90. [
DOI:10.54319/jjbs/140213]
47. Elemo O, Ishola I and Olayemi S. Hypolipidaemic and antioxidant effects of Citrus aurantifolia fruit juice. University of Lagos Journal of Basic Medical Sciences. 2014; 2(2): 22-9.
48. Sivasubramanian P, Gayathri R, Priya VV, Selvaraj J and Kavitha S. Evaluation of anti cholesterol and antioxidant potentiality of aqueous extracts of Citrus aurantifolia, Zingiber officinale and its formulation - a comparative In vitro study. JPRI. 2021; 33(60B): 1873-82. [
DOI:10.9734/jpri/2021/v33i60B34820]
49. Kazeem MI, Bankole HA, Oladokun TI, Bello AO and Maliki MA. Citrus aurantifolia (Christm.) Swingle (lime) fruit extract inhibits the activities of Polyol pathway enzymes. eFood. 2020; 1(4): 310-5. [
DOI:10.2991/efood.k.200824.001]